Interference with distinct steps of sphingolipid synthesis and signaling attenuates proliferation of U87MG glioma cells

作者: Eva Bernhart , Sabine Damm , Andrea Wintersperger , Christoph Nusshold , Anna Martina Brunner

DOI: 10.1016/J.BCP.2015.05.007

关键词: RNA interferenceMyriocinGliomaSignal transductionCeramideBiologySphingolipidCell biologyGene silencingCell growth

摘要: Glioblastoma is the most common malignant brain tumor, which, despite combined radio- and chemotherapy, recurs invariably fatal for affected patients. Members of sphingolipid (SL) family are potent effectors glioma cell proliferation. In particular sphingosine-1-phosphate (S1P) corresponding G protein-coupled S1P receptors transmit proliferative signals to cells. To investigate contribution proliferation we inhibited first step de novo SL synthesis in p53wt p53mut cells, interfered with signaling specifically U87MG Subunit silencing (RNAi) or pharmacological antagonism (using myriocin) serine palmitoyltransferase (SPT; catalyzing committed biosynthesis) reduced but not GBM cells these observations were accompanied by decreased ceramide, sphingomyelin, content. Inhibition SPT upregulated p53 p21 expression induced an increase early late apoptotic Exogenously added (complexed physiological carriers) increased line, individual members receptor Silencing inhibition ATP-dependent cassette transporter A1 (ABCA1) that facilitates efflux astrocytes attenuated growth. Glyburide-mediated ABCA1 resulted intracellular accumulation raising possibility promotes thereby contributing inside-out signaling. Our findings indicate synthesis, receptor-mediated signaling, ABCA1-mediated could provide targets interfere

参考文章(69)
Christopher R. Gault, Lina M. Obeid, Yusuf A. Hannun, An overview of sphingolipid metabolism: from synthesis to breakdown. Advances in Experimental Medicine and Biology. ,vol. 688, pp. 1- 23 ,(2010) , 10.1007/978-1-4419-6741-1_1
Y.-S. Lee, K.-M. Choi, M.-H. Choi, S.-Y. Ji, S. Lee, D.-M. Sin, K.-W. Oh, Y.-M. Lee, J.-T. Hong, Y.-P. Yun, H.-S. Yoo, Serine palmitoyltransferase inhibitor myriocin induces growth inhibition of B16F10 melanoma cells through G(2) /M phase arrest Cell Proliferation. ,vol. 44, pp. 320- 329 ,(2011) , 10.1111/J.1365-2184.2011.00761.X
Oleksandr Pastukhov, Stephanie Schwalm, Uwe Zangemeister-Wittke, Doriano Fabbro, Frederic Bornancin, Lukasz Japtok, Burkhard Kleuser, Josef Pfeilschifter, Andrea Huwiler, The ceramide kinase inhibitor NVP-231 inhibits breast and lung cancer cell proliferation by inducing M phase arrest and subsequent cell death. British Journal of Pharmacology. ,vol. 171, pp. 5829- 5844 ,(2014) , 10.1111/BPH.12886
Yusuf A. Hannun, Lina M. Obeid, Principles of bioactive lipid signalling: lessons from sphingolipids Nature Reviews Molecular Cell Biology. ,vol. 9, pp. 139- 150 ,(2008) , 10.1038/NRM2329
Jean-Philip Truman, Mónica García-Barros, Lina M. Obeid, Yusuf A. Hannun, Evolving concepts in cancer therapy through targeting sphingolipid metabolism Biochimica et Biophysica Acta. ,vol. 1841, pp. 1174- 1188 ,(2014) , 10.1016/J.BBALIP.2013.12.013
Enkhzol Malchinkhuu, Koichi Sato, Tomohiko Maehama, Chihiro Mogi, Hideaki Tomura, Shogo Ishiuchi, Yuhei Yoshimoto, Hitoshi Kurose, Fumikazu Okajima, S1P2 receptors mediate inhibition of glioma cell migration through Rho signaling pathways independent of PTEN Biochemical and Biophysical Research Communications. ,vol. 366, pp. 963- 968 ,(2008) , 10.1016/J.BBRC.2007.12.054
Gerald Eibinger, Günter Fauler, Eva Bernhart, Sasa Frank, Astrid Hammer, Andrea Wintersperger, Hans Eder, Akos Heinemann, Paul S. Mischel, Ernst Malle, Wolfgang Sattler, On the role of 25-hydroxycholesterol synthesis by glioblastoma cell lines. Implications for chemotactic monocyte recruitment. Experimental Cell Research. ,vol. 319, pp. 1828- 1838 ,(2013) , 10.1016/J.YEXCR.2013.03.025
Mohammed Dany, Besim Ogretmen, Ceramide induced mitophagy and tumor suppression Biochimica et Biophysica Acta. ,vol. 1853, pp. 2834- 2845 ,(2015) , 10.1016/J.BBAMCR.2014.12.039
Besim Ogretmen, Yusuf A. Hannun, Biologically active sphingolipids in cancer pathogenesis and treatment. Nature Reviews Cancer. ,vol. 4, pp. 604- 616 ,(2004) , 10.1038/NRC1411